By Sarah Keane • Published: 30 Dec 2020 • 13:59
NOVAVAX launches final US trial before seeking FDA approval
After several manufacturing delays, Novavax bosses announced On Monday, December 28 that the Covid vaccine is ready for the last series of trials. While Pfizer and Moderna vaccines have already received approval in the US, Novavax has yet to announce a finish date; however, sources from the company expect preliminary data to be ready by March 2021.
The news comes after the UK announced the approval of Oxford University’s coronavirus vaccine on December 30. The UK has also pre-ordered 60 million doses of the Novavax jab.
Up to 30,000 volunteers will participate in the latest Novavax trial from across the United States and Mexico, with two-thirds receiving the experimental Covid-19 vaccine and the rest a placebo.
________________________________________________________________________
Thank you for taking the time to read this news article “Novavax Launches Final US Trial”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Former teacher and health services manager with a Degree in English, Sarah moved to Spain from Southern Ireland with her husband, who runs his own car rental business, in 2019. She is now enjoying a completely different pace and quality of life on the Costa Blanca South, with wonderful Spanish and expat friends in Cabo Roig. Sarah began working with Euro Weekly News in 2020 and loves nothing more than bringing all the latest national and international news to her local community.
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.